380 related articles for article (PubMed ID: 37446024)
21. Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional Group.
Cancrini F; Osman N; Doizi S; Guillot-Tantay C; Hüsch T; Illiano E; Tutolo M; Tienza A; Culha MG; Vale L; Raison N; Herve F; Grande P; Roupret M; Phé V
Minerva Urol Nephrol; 2023 Apr; 75(2):163-171. PubMed ID: 36999836
[TBL] [Abstract][Full Text] [Related]
22. [The clinical usefulness of urinary basic fetoprotein (BFP) in patients with urological malignancies].
Tsujii T; Yonese J; Kojima S; Tari K; Ishii M; Seino Y
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):829-34. PubMed ID: 1698231
[TBL] [Abstract][Full Text] [Related]
23. [Urologic malignancies in renal transplant candidates and recipients].
Kleinclauss F; Thuret R; Murez T; Timsit MO
Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
[TBL] [Abstract][Full Text] [Related]
24. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
Netto GJ
Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
[TBL] [Abstract][Full Text] [Related]
25. The role of methylation in urological tumours.
van der Heijden AG
Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
[TBL] [Abstract][Full Text] [Related]
26. The current landscape of m6A modification in urological cancers.
Zeng Y; Lv C; Wan B; Gong B
PeerJ; 2023; 11():e16023. PubMed ID: 37701836
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic and predictive molecular markers for urologic cancers].
Hartmann A; Schlomm T; Bertz S; Heinzelmann J; Hölters S; Simon R; Stoehr R; Junker K
Urologe A; 2014 Apr; 53(4):491-500. PubMed ID: 24700189
[TBL] [Abstract][Full Text] [Related]
28. Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers.
Tortora F; La Civita E; Trivedi P; Febbraio F; Terracciano D; Cimmino A
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902032
[TBL] [Abstract][Full Text] [Related]
29. Serotonin used as prognostic marker of urological tumors.
Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
31. Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers.
Ruiz de Porras V; Font A
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958779
[TBL] [Abstract][Full Text] [Related]
32. Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.
Kurozumi A; Goto Y; Okato A; Ichikawa T; Seki N
J Hum Genet; 2017 Jan; 62(1):49-56. PubMed ID: 27357429
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.
Fedorko M; Pacik D; Wasserbauer R; Juracek J; Varga G; Ghazal M; Nussir MI
Int J Biol Markers; 2016 Feb; 31(1):e26-37. PubMed ID: 26481440
[TBL] [Abstract][Full Text] [Related]
34. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
35. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
36. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract][Full Text] [Related]
37. Genetics of urological cancers.
Maher ER
Br Med Bull; 1994 Jul; 50(3):698-707. PubMed ID: 7987649
[TBL] [Abstract][Full Text] [Related]
38. Genomics in upper tract urothelial carcinoma.
Kammerer-Jacquet SF; Mathieu R; Peyronnet B; Rioux-Leclercq N; Bensalah K
Curr Opin Urol; 2017 Jan; 27(1):35-40. PubMed ID: 27584028
[TBL] [Abstract][Full Text] [Related]
39. Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma.
Urabe F; Matsuzaki J; Takeshita F; Kishida T; Ochiya T; Hirai K
Cancer Sci; 2022 Oct; 113(10):3510-3517. PubMed ID: 35848873
[TBL] [Abstract][Full Text] [Related]
40. Plasma microRNA profiles for bladder cancer detection.
Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP
Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
